Literature DB >> 16825279

Different transitions of multifocal electroretinogram recordings between patients with age-related macular degeneration and polypoidal choroidal vasculopathy after photodynamic therapy.

H Imai1, S Honda, Y Nakanishi, H Yamamoto, Y Tsukahara, A Negi.   

Abstract

AIM: To compare and evaluate the transitions in retinal function after photodynamic therapy (PDT) between age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV) using multifocal electroretinograms (mfERGs).
METHODS: 10 eyes with choroidal neovascularisation (CNV) secondary to AMD and 11 eyes with CNV secondary to PCV were included in the study. mfERGs were recorded before PDT, and 1 week and 3 months after PDT. mfERG recordings were acquired by a Veris system (V.3.1.3) using a 103 hexagon stimulus. The first-order kernel was used to calculate amplitudes and latencies. Mean amplitudes and latencies from two central rings rated 0-4 degrees of visual angle were analysed and compared with each disease.
RESULTS: In AMD, the mean first negative peak (N1) amplitudes tended to decrease, and the mean first positive peak (N1P1) amplitudes reduced to significant levels (p = 0.047) 1 week after PDT. 3 months after PDT, there were no significant differences in the mean N1 and N1P1 amplitudes compared with pre-PDT values. In PCV, there were no significant changes in the mean N1 and N1P1 amplitudes 1 week after treatment. However, 3 months after PDT, mean amplitudes showed significant increases in N1 (p = 0.008) and N1P1 (p = 0.006) amplitudes compared with pre-PDT values.
CONCLUSIONS: mfERG recording transitions are different between patients with AMD and those with PCV. In patients with AMD, these results may show transient impairments in retinal function 1 week after PDT, but in those with PCV, the efficacy of PDT is superior to the impairment after PDT.

Entities:  

Mesh:

Year:  2006        PMID: 16825279      PMCID: PMC1857528          DOI: 10.1136/bjo.2006.092783

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  36 in total

1.  The changes of multifocal electroretinography in the early stage of photodynamic therapy for choroidal neovascularization.

Authors:  Libin Jiang; Chenjin Jin; Feng Wen; Shizhou Huang; Dezheng Wu; Lezheng Wu
Journal:  Doc Ophthalmol       Date:  2003-09       Impact factor: 2.379

2.  Multiple recurrent serosanguineous retinal pigment epithelial detachments in black women.

Authors:  R M Stern; Z N Zakov; H Zegarra; F A Gutman
Journal:  Am J Ophthalmol       Date:  1985-10-15       Impact factor: 5.258

3.  The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy.

Authors:  L A Yannuzzi; A Ciardella; R F Spaide; M Rabb; K B Freund; D A Orlock
Journal:  Arch Ophthalmol       Date:  1997-04

4.  The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975.

Authors:  H M Leibowitz; D E Krueger; L R Maunder; R C Milton; M M Kini; H A Kahn; R J Nickerson; J Pool; T L Colton; J P Ganley; J I Loewenstein; T R Dawber
Journal:  Surv Ophthalmol       Date:  1980 May-Jun       Impact factor: 6.048

5.  Idiopathic polypoidal choroidal vasculopathy in Japanese patients.

Authors:  M Uyama; T Matsubara; I Fukushima; H Matsunaga; K Iwashita; Y Nagai; K Takahashi
Journal:  Arch Ophthalmol       Date:  1999-08

6.  Idiopathic polypoidal choroidal vasculopathy (IPCV).

Authors:  L A Yannuzzi; J Sorenson; R F Spaide; B Lipson
Journal:  Retina       Date:  1990       Impact factor: 4.256

7.  Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.

Authors:  D Husain; M Kramer; A G Kenny; N Michaud; T J Flotte; E S Gragoudas; J W Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-09       Impact factor: 4.799

8.  Photodynamic therapy with verteporfin for symptomatic polypoidal choroidal vasculopathy: one-year results of a prospective case series.

Authors:  Wai-Man Chan; Dennis S C Lam; Timothy Y Y Lai; David T L Liu; Kenneth K W Li; Yi Yao; Tak-Hung Wong
Journal:  Ophthalmology       Date:  2004-08       Impact factor: 12.079

Review 9.  Polypoidal choroidal vasculopathy.

Authors:  Antonio P Ciardella; Irene M Donsoff; Sheau J Huang; Danielle L Costa; Lawrence A Yannuzzi
Journal:  Surv Ophthalmol       Date:  2004 Jan-Feb       Impact factor: 6.048

10.  Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy.

Authors:  Timothy Y Y Lai; Wai-Man Chan; Dennis S C Lam
Journal:  Am J Ophthalmol       Date:  2004-05       Impact factor: 5.258

View more
  8 in total

1.  Transitions of multifocal electroretinography following combined intravitreal bevacizumab and photodynamic therapy for polypoidal choroidal vasculopathy.

Authors:  Chengguo Zuo; Feng Wen; Jiaqing Li; Yan Liu; Meng Li
Journal:  Doc Ophthalmol       Date:  2009-01-31       Impact factor: 2.379

2.  Transitions of multifocal electroretinography in patients with age-related macular degeneration after combination therapy with photodynamic therapy and intravitreal bevacizumab.

Authors:  Yan Liu; Feng Wen; Jiaqing Li; Chengguo Zuo; Meng Li
Journal:  Doc Ophthalmol       Date:  2009-12       Impact factor: 2.379

Review 3.  Idiopathic polypoidal choroidal vasculopathy: a review of literature with clinical update on current management practices.

Authors:  Yamini Sahu; Niharika Chaudhary; Mukesh Joshi; Aastha Gandhi
Journal:  Int Ophthalmol       Date:  2020-10-20       Impact factor: 2.031

4.  Determinants of patient satisfaction with photodynamic therapy for neovascular age-related macular degeneration or polypoidal choroidal vasculopathy.

Authors:  Kenji Yamashiro; Akitaka Tsujikawa; Akihiro Nishida; Yasuo Kurimoto
Journal:  Jpn J Ophthalmol       Date:  2007-10-05       Impact factor: 2.447

5.  Transcranial Focused Ultrasound for Noninvasive Neuromodulation of the Visual Cortex.

Authors:  Gengxi Lu; Xuejun Qian; Johnny Castillo; Runze Li; Laiming Jiang; Haotian Lu; K Kirk Shung; Mark S Humayun; Biju B Thomas; Qifa Zhou
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2020-12-23       Impact factor: 2.725

6.  COL1A2 polymorphic markers confer an increased risk of neovascular age-related macular degeneration in a Han Chinese population.

Authors:  Chengguo Zuo; Feng Wen; Meng Li; Xiongze Zhang; Hui Chen; Kunfang Wu; Renpan Zeng
Journal:  Mol Vis       Date:  2012-06-30       Impact factor: 2.367

7.  Structure versus function: correlation between outer retinal and choroidal thicknesses measured by swept-source OCT with multifocal electroretinography and visual acuity.

Authors:  Ignacio Flores-Moreno; Luis Arias-Barquet; Marcos J Rubio-Caso; Alex Muñoz-Blanco; María Vidal-Martí; Jaume Catala-Mora; José M Ruiz-Moreno; Jay S Duker; Josep M Caminal
Journal:  Int J Retina Vitreous       Date:  2017-08-07

Review 8.  Polypoidal choroidal vasculopathy: Pearls in diagnosis and management.

Authors:  Giridhar Anantharaman; Jay Sheth; Muna Bhende; Raja Narayanan; Sundaram Natarajan; Anand Rajendran; George Manayath; Parveen Sen; Rupak Biswas; Alay Banker; Charu Gupta
Journal:  Indian J Ophthalmol       Date:  2018-07       Impact factor: 1.848

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.